1. Home
  2. VTMX vs IDYA Comparison

VTMX vs IDYA Comparison

Compare VTMX & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

N/A

Current Price

$34.58

Market Cap

3.1B

Sector

N/A

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$25.63

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTMX
IDYA
Founded
1998
2015
Country
Mexico
United States
Employees
N/A
145
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.5B
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
VTMX
IDYA
Price
$34.58
$25.63
Analyst Decision
Hold
Strong Buy
Analyst Count
4
15
Target Price
$39.48
★ $50.15
AVG Volume (30 Days)
118.2K
★ 1.1M
Earning Date
10-22-2026
11-03-2026
Dividend Yield
★ 2.39%
N/A
EPS Growth
N/A
★ 61.90
EPS
★ N/A
N/A
Revenue
N/A
★ $218,710,000.00
Revenue This Year
$21.49
N/A
Revenue Next Year
$8.75
$186.04
P/E Ratio
$47.91
★ N/A
Revenue Growth
N/A
★ 3024.43
52 Week Low
$29.86
$25.75
52 Week High
$38.59
$42.68

Technical Indicators

Market Signals
Indicator
VTMX
IDYA
Relative Strength Index (RSI) 36.82 24.75
Support Level $33.52 N/A
Resistance Level $34.98 $29.74
Average True Range (ATR) 0.89 1.73
MACD -0.44 -0.54
Stochastic Oscillator 7.52 0.47

Price Performance

Historical Comparison
VTMX
IDYA

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: